Overview: Core technical elements for early product development, evaluation, and control of human cell-based products

Area of Science:

• Cellular therapy development
• Biotechnology
• Human cell-based products

Background:

• Addresses critical scientific elements for early-stage development, evaluation, and control of human cell-based products.
• Highlights the interconnectedness of donor issues (autologous and allogeneic), raw material testing, cell banking, cell substrate characterization, adventitious agent testing (viral safety), and product sterility.

Framework:

• Leverages existing expertise from traditional biologicals and biotechnology products.
• Core principles, concepts, and testing methodologies are well-established for several key areas.

Implementation:

• Focuses on a comprehensive and unifying approach to product development and control.
• Acknowledges areas requiring further discussion on regulatory requirements and testing methods.

Implications:

• Provides a foundational understanding for consistent and safe cell therapy development.
• Guides future research and regulatory discussions for critical technical elements.